Gene · 6286
Papers2,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network of interactions between the tumor necrosis factor superfamily members and small S100 proteins. | PLoS One | 2026 | 42809589 | PubTator, text mining | PubMed |
| Multi-Omics Integration Identifies Epithelial-Stromal-Immune Co-Regulators Bridging Ulcerative Colitis and Colorectal Cancer. | Biomedicines | 2026 | 42792859 | PubTator, text mining | PubMed |
| Identifying JAK2 and ANXA5 as Key Genes Linking Obstructive Sleep Apnea and Oxidative Stress via Machine Learning and Multilayer Transcriptomic Integration With Functional Validation. | FASEB J | 2026 | 42730994 | PubTator, text mining | PubMed |
| S100P as a Shared Biomarker in Inflammatory Bowel Disease, Colorectal Cancer, and Pancreatic Adenocarcinoma: An Integrated Transcriptomic Analysis. | J Vis Exp | 2026 | 42611775 | PubTator, text mining | PubMed |
| Proteomic Tear Fluid Analysis in Acute Anterior Uveitis Reveals Distinct Characteristics During Active Inflammation. | Ocul Immunol Inflamm | 2026 | 42605717 | PubTator, text mining | PubMed |
| Screening for candidate genes and cell populations associated with atherosclerotic calcification using single-cell RNA sequencing. | Mamm Genome | 2026 | 42581084 | PubTator, text mining | PubMed |
| High-throughput microfluidics and machine learning-assisted screening of lipid nanoparticle formulations for siRNA delivery. | Mater Today Bio | 2026 | 42569578 | PubTator, text mining | PubMed |
| Integrative Analysis of Intestinal Transcriptomes Underscores C2 Upregulation in IBD, AIG, EoE, and CRC. | Bioinform Biol Insights | 2026 | 42559028 | PubTator, text mining | PubMed |
| Unraveling the roles of DKK1 and S100P in pancreatic ductal adenocarcinoma: Insights from machine learning, single-cell/spatial transcriptomics, and functional validation. | Transl Oncol | 2026 | 42537428 | PubTator, text mining | PubMed |
| [Expression of S100P in Lung Adenocarcinoma and Its Clinical Significance]. | Zhongguo Fei Ai Za Zhi | 2026 | 42452863 | PubTator, text mining | PubMed |
| Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression. | PLoS One | 2026 | 42384634 | PubTator, text mining | PubMed |
| Integrative Transcriptomic and Proteomic Profiling Identifies S100P as a Potential Functional Biomarker for Sessile Serrated Lesions. | Dig Dis Sci | 2026 | 42332159 | PubTator, text mining | PubMed |
| The Utility of SMAD4 and S100P as Diagnostic Immunohistochemical Markers for Pancreatic Ductal Adenocarcinomas in Egyptian Patients. | J Microsc Ultrastruct | 2026 | 42325236 | PubTator, text mining | PubMed |
| Integrated multi-omics characterization of SPTBN2 overexpression reveals its pro-tumorigenic role and immune microenvironment remodeling in colorectal cancer. | Front Cell Dev Biol | 2026 | 42238893 | PubTator, text mining | PubMed |
| Idiopathic Intracranial Hypertension Is Characterized by a Distinct Proteomic Profile. | Ann Neurol | 2026 | 42206744 | PubTator, text mining | PubMed |
| Activity of epidermal growth factor is directly affected by S100 proteins. | Cell Calcium | 2026 | 42190582 | PubTator, text mining | PubMed |
| S100 Calcium-Binding Protein P Predicts Early Recurrence and Poor Survival in Distal Cholangiocarcinoma: A Proteomics Study. | J Proteome Res | 2026 | 42136396 | PubTator, text mining | PubMed |
| A Complement and Coagulation Cascade-Related Prognostic Signature Predicts Survival and Immune Landscape in Lung Adenocarcinoma. | Curr Gene Ther | 2026 | 42136237 | PubTator, text mining | PubMed |
| An integrative multi-modal computational framework identified hub prognostic targets and natural inhibitors for tobacco-specific nitrosamine-induced lung adenocarcinoma. | Comput Biol Chem | 2026 | 42107350 | PubTator, text mining | PubMed |
| S100P mediates IL-13/ATF4-driven epithelial barrier dysfunction in eosinophilic asthma: a potential biomarker and therapeutic target. | J Transl Med | 2026 | 42032605 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6286/papers